EUVIMEDEUVIMED entdecken
Crossref

The small nucleolar RNA SNORA51 enhances breast cancer stem cell‐like properties via the RPL3/NPM1/c‐MYC pathway

Shan Li, Zining Jin, Xinyue Song iD, Jinfei Ma, Ziqi Peng, Hao Yu, Jian Song, Yiqi Zhang, Xiaoyu Sun, Miao He, Xinmiao Yu iD, Feng Jin iD und 1 weitere

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Shan Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Cell Proliferation, Neoplastic Stem Cells, Nucleophosmin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province, Chinese Breast Surgery Young Doctor Research Support Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer stem cells (BCSCs) are key players in carcinogenesis and development. Small nucleolar RNAs (snoRNAs) seem to have a crucial influence on regulating stem cell‐like properties in various cancers, but the underlying mechanism in breast cancer has not been determined. In this study, we first found that the expression of SNORA51 might be strongly and positively related to BCSCs‐like properties. SNORA51 expression was assessed in breast cancer tissues ( n = 158 patients) by in situ hybridization. Colony formation, cell counting kit‐8, and sphere formation assays were used to detect cell proliferation and self‐renewal, respectively. Wound healing and transwell assays were used to detect cell migration. Coimmunoprecipitation and molecular docking were used to determine the underlying mechanism through which SNORA51 regulates BCSCs‐like properties. High SNORA51 expression was associated with a worse prognosis, overall survival, and disease‐free survival, in 158 breast cancer patients and was also closely related to lymph node status, ER status, the Ki‐67 index, histological grade, and TNM stage. Further analysis proved that SNORA51 could enhance and maintain stem cell‐like properties, including cell proliferation, self‐renewal, and migration, in breast cancer. Moreover, high SNORA51 expression could reduce nucleolar RPL3 expression, induce changes in the expression of NPM1 in the nucleolus and nucleoplasm, and ultimately increase c‐MYC expression. Taken together, our findings demonstrated that SNORA51 could enhance BCSCs‐like properties via the RPL3/NPM1/c‐MYC pathway both in vitro and in vivo. Therefore, SNORA51 might be a significant biomarker and potential therapeutic target and might even provide a new viewpoint on the regulatory mechanism of snoRNAs in breast cancer or other malignant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCell ProliferationNeoplastic Stem CellsNucleophosminProto-Oncogene Proteins c-mycRNA, Small NucleolarRibosomal Protein L3AnimalsFemaleHumansMiceCell Line, TumorCell MovementGene Expression Regulation, NeoplasticNuclear ProteinsPrognosisRibosomal ProteinsSignal Transduction

Stichwörter der Autor:innen

NPM1/c‐MYC pathwaybreast cancer stem cellprognosisribosomal protein L3small nucleolar RNA 51

Substanzen

Nuclear ProteinsNucleophosminProto-Oncogene Proteins c-mycRibosomal ProteinsRNA, Small NucleolarRPL3 protein, humanNPM1 protein, humanRibosomal Protein L3

Autor:innen und Institutionen

  • Department of Breast Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, China.
  • Department of Breast Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.

ORCID-Profile: Xinyue Song, Xinmiao Yu, Feng Jin

Förderung

  • Natural Science Foundation of Liaoning Province
  • Chinese Breast Surgery Young Doctor Research Support Project
  • National Natural Science Foundation of China

Zitieren

APA

Li, S., Jin, Z., Song, X., Ma, J., Peng, Z., Yu, H., Song, J., Zhang, Y., Sun, X., He, M., Yu, X., Jin, F., & Zheng, A. (2024). The small nucleolar RNA SNORA51 enhances breast cancer stem cell‐like properties via the RPL3/NPM1/c‐MYC pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23713

Vancouver

Li S, Jin Z, Song X, Ma J, Peng Z, Yu H, et al. The small nucleolar RNA SNORA51 enhances breast cancer stem cell‐like properties via the RPL3/NPM1/c‐MYC pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23713

BibTeX
@article{Li2024,
  author = {Li, Shan and Jin, Zining and Song, Xinyue and Ma, Jinfei and Peng, Ziqi and Yu, Hao and Song, Jian and Zhang, Yiqi and Sun, Xiaoyu and He, Miao and Yu, Xinmiao and Jin, Feng and Zheng, Ang},
  title = {The small nucleolar RNA SNORA51 enhances breast cancer stem cell‐like properties via the RPL3/NPM1/c‐MYC pathway},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23713}
}
Kostenlos starten →